THE EFFICACY OF ATOMOXETINE AS ADJUNCTIVE TREATMENT FOR CO-MORBID ATTENTION DEFICIT HYPERACTIVITY AND SUBSTANCE USE DISORDERS

被引：0
|
作者：
Viswanath, B. [1 ]
Narayanaswamy, J. C. [1 ]
Jose, S. P. [1 ]
Chakraborthy, V. [1 ]
Muralidharan, K. [1 ]
Benegal, V. [1 ]
机构：
[1] Natl Inst Mental Hlth & Neurosci, Dept Psychiat, Deaddict Ctr, Bangalore 560029, Karnataka, India
来源：
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH | 2010年 / 34卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
引用
收藏
页码：179A / 179A
页数：1
相关论文
共 50 条
  • [1] THE EFFICACY OF ATOMOXETINE AS ADJUNCTIVE TREATMENT FOR CO-MORBID ATTENTION DEFICIT HYPERACTIVITY DISORDER AND ALCOHOLISM AND OTHER SUBSTANCE USE DISORDERS
    Benegal, V.
    Viswanath, B.
    Muralidharan, K.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 34 (08) : 154A - 154A
  • [2] The efficacy of atomoxetine as adjunctive treatment for co-morbid substance use disorders and externalizing symptoms
    Benegal, Vivek
    Viswanath, Biju
    Narayanaswamy, Janardhanan C.
    Jose, Sam P.
    Chakraborty, Vaskar
    Sankar, Deepa
    Kandavel, Thennarasu
    Kesavan, Muralidharan
    [J]. ASIAN JOURNAL OF PSYCHIATRY, 2013, 6 (06) : 544 - 547
  • [3] Use of Atomoxetine in Patients with Attention-Deficit Hyperactivity Disorder and Co-Morbid Conditions
    Dell'Agnello, Grazia
    Zuddas, Alessandro
    Masi, Gabriele
    Curatolo, Paolo
    Besana, Dante
    Rossi, Andrea
    [J]. CNS DRUGS, 2009, 23 (09) : 739 - 753
  • [4] Use of Atomoxetine in Patients with Attention-Deficit Hyperactivity Disorder and Co-Morbid Conditions
    Grazia Dell’Agnello
    Alessandro Zuddas
    Gabriele Masi
    Paolo Curatolo
    Dante Besana
    Andrea Rossi
    [J]. CNS Drugs, 2009, 23 : 739 - 753
  • [5] Towards Precision Addiction Treatment: New Findings in Co-morbid Substance Use and Attention-Deficit Hyperactivity Disorders
    Luo, Sean X.
    Levin, Frances R.
    [J]. CURRENT PSYCHIATRY REPORTS, 2017, 19 (03)
  • [6] Towards Precision Addiction Treatment: New Findings in Co-morbid Substance Use and Attention-Deficit Hyperactivity Disorders
    Sean X. Luo
    Frances R. Levin
    [J]. Current Psychiatry Reports, 2017, 19
  • [7] Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample
    Steinhausen, Hans-Christoph
    Bisgaard, Charlotte
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 (02) : 232 - 241
  • [8] Efficacy of clonidine in the treatment of children with tic disorder co-morbid with attention deficit hyperactivity disorder
    Zeng, K. -D.
    Wang, G. -L.
    Yuan, Y.
    Zhang, W.
    Huang, X. -H.
    Hu, B.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (09) : 4232 - 4238
  • [9] Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence
    Cunill, R.
    Castells, X.
    Tobias, A.
    Capella, D.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2015, 29 (01) : 15 - 23
  • [10] Milnacipran and atomoxetine: treatment of depressive disorder with co-morbid hyperactivity disorder
    Martsenkovsky, I.
    Martsenkovska, I. I.
    Bikshaeva, Y. B.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S373 - S374
12345